Earnings Preview: IDXX to Report Financial Results Pre-market on May 01
A Look Into IDEXX Laboratories Inc's Price Over Earnings
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $475
Bank of America Securities Reaffirms Their Hold Rating on Idexx Laboratories (IDXX)
Notable Healthcare Headlines for the Week: UnitedHealth, Eli Lilly, J&J in Focus
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $548
Morgan Stanley Adjusts IDEXX Laboratories' Price Target to $548 From $559, Keeps Overweight Rating
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $420
A Look At The Intrinsic Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
IDEXX Labs Price Target Cut to $420.00/Share From $450.00 by Stifel
IDEXX Laboratories Analyst Ratings
Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $510
ImmuCell Names Timothy Fiori Finance Chief
Should You Sell IDEXX Laboratories (IDXX)?
How Is The Market Feeling About IDEXX Laboratories?
Press Release: IDEXX Laboratories to Release 2025 First Quarter Financial Results
Pets at Home Is Well-Positioned Despite Current Weak Demand -- Market Talk
Investing in IDEXX Laboratories (NASDAQ:IDXX) Five Years Ago Would Have Delivered You a 77% Gain
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com